Image

Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer

Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis

Eligibility

Inclusion Criteria:

  • ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.
    • FIGO 2014 stage IA-IVB.
    • Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
    • Patients with no residual disease after surgery.
    • Patients with ECOG performance status 0-1.

Exclusion Criteria:

  • ◦ Patients without epithelial ovarian cancer.
    • Patients with ECOG 2-4.
    • Patients who do not consent to participate in the study.
    • Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.

Study details
    Ovarian Cancer
    Ovarian Cancer (OvCa)
    Ovarian Adenocarcinoma

NCT07100288

Complejo Hospitalario Universitario Insular Materno Infantil

9 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.